The Impact of Stationary Combined Exercise on Adiponectin and Hs-CRP Levels in Overweight Women
SCEX-ADCRP
2 other identifiers
interventional
22
1 country
1
Brief Summary
This study looked at whether a specific exercise program can improve inflammatory markers in overweight young women. We tested an eight-week, circuit-style exercise program that combines aerobic and resistance activities (e.g., sit-ups, step jumps, push-ups, jump rope, jumping jacks, medicine-ball lifts). Participants exercised four times per week at a moderate-to-high intensity, with a warm-up and cool-down at each session. Twenty-two women (ages 20-30 years; BMI 25-31 kg/m²) were randomly assigned to one of two groups: (1) the exercise group completed the training program; (2) the control group continued usual daily activities without a structured program. Before starting and 48 hours after finishing the program, we took fasting blood samples to measure two markers: adiponectin (a hormone made by fat tissue that supports healthy metabolism and has anti-inflammatory effects) and high-sensitivity C-reactive protein (hs-CRP) (a blood marker of inflammation and cardiovascular risk). The main outcomes were the changes in adiponectin and hs-CRP from before to after the 8-week period. We also recorded weight, body mass index (BMI), body fat percentage, and fitness (VO₂max). The study was conducted at the Exercise Physiology Laboratory, College of Physical Education and Health, Chongqing College of International Business and Economics (Chongqing, China). The research ethics committee approved the protocol, and all participants provided written informed consent. Recruitment and data collection are complete. Findings suggest that this circuit-based exercise program can increase adiponectin and lower hs-CRP, alongside improvements in body composition, in overweight young women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 10, 2024
CompletedFirst Submitted
Initial submission to the registry
September 13, 2025
CompletedFirst Posted
Study publicly available on registry
November 17, 2025
CompletedNovember 19, 2025
November 1, 2025
3 months
September 13, 2025
November 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Serum Adiponectin Concentration
Serum adiponectin (µg/mL) quantified by ELISA in the fasting state; difference from baseline to 48 hours after completion of the 8-week exercise program.
Baseline and 48 hours post-intervention (end of week 8).
Secondary Outcomes (1)
Change in Serum Adiponectin Concentration
Baseline and 48 hours post-intervention (end of week 8).
Study Arms (2)
Combined Exercise Group
EXPERIMENTALArm 1 reflects the circuit-based combined exercise intervention.
Control Group
EXPERIMENTALArm 2 reflects the no structured exercise condition.
Interventions
Participants completed an eight-week circuit-based combined exercise program, four sessions per week, at an intensity of 70-90% of maximum heart rate. Each session began with a 10-15 minute warm-up (stretching and light jogging) and ended with a 5-10 minute cool-down (walking and stretching). The main exercise protocol included six stations (sit-ups, step jumps, push-ups, jump rope, jumping jacks, and medicine ball lifting), performed in three rounds. The duration at each station progressively increased from 60 seconds (weeks 1-2) to 150 seconds (weeks 7-8), with rest intervals of 30-50 seconds between stations and 3-5 minutes between rounds. Exercise intensity was monitored with a Polar heart rate monitor to ensure participants stayed within the target zone.
Participants in the control group will not receive any structured exercise program during the eight-week study period. They will be instructed to maintain their usual daily routines and refrain from initiating any new organized exercise or training programs beyond their routine physical education classes and everyday activities.
Eligibility Criteria
You may qualify if:
- Female sex Age 20 to 30 years BMI 25 to 31 kg/m² Body weight 63 to 87 kg Generally healthy, without diagnosed chronic illness Willing and able to provide written informed consent Willing to refrain from vigorous physical activity for 48 hours before blood sampling Able to attend 4 supervised training sessions per week for 8 weeks (if assigned to intervention)
You may not qualify if:
- History of cardiovascular disease, hypertension, or diabetes Current smoking or tobacco use Current use of medications or supplements that affect metabolism or inflammatory markers Pregnancy or breastfeeding Contraindications to moderate-to-high intensity exercise on screening Participation in regular vigorous exercise training within the past 6 months Inability or unwillingness to comply with study procedures (e.g., missing \>2 consecutive training sessions)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xianjie Zhenglead
Study Sites (1)
College of Physical Education and Health
Chongqing, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- College of Physical Education and Health
Study Record Dates
First Submitted
September 13, 2025
First Posted
November 17, 2025
Study Start
January 20, 2024
Primary Completion
April 10, 2024
Study Completion
April 10, 2024
Last Updated
November 19, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share